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Abstract
Neuronal degeneration is a hallmark of many DNA repair syndromes. Yet, how DNA damage causes neuronal degeneration
and whether defects in different repair systems affect the brain differently is largely unknown. Here, we performed a
systematic detailed analysis of neurodegenerative changes in mouse models deficient in nucleotide excision repair (NER)
and transcription-coupled repair (TCR), two partially overlapping DNA repair systems that remove helix-distorting and
transcription-blocking lesions, respectively, and that are associated with the UV-sensitive syndromes xeroderma
pigmentosum (XP) and Cockayne syndrome (CS). TCR–deficient Csa
2/2 and Csb
2/2 CS mice showed activated microglia
cells surrounding oligodendrocytes in regions with myelinated axons throughout the nervous system. This white matter
microglia activation was not observed in NER–deficient Xpa
2/2 and Xpc
2/2 XP mice, but also occurred in Xpd
XPCS mice
carrying a point mutation (G602D) in the Xpd gene that is associated with a combined XPCS disorder and causes a partial
NER and TCR defect. The white matter abnormalities in TCR–deficient mice are compatible with focal dysmyelination in CS
patients. Both TCR–deficient and NER–deficient mice showed no evidence for neuronal degeneration apart from p53
activation in sporadic (Csa
2/2, Csb
2/2) or highly sporadic (Xpa
2/2, Xpc
2/2) neurons and astrocytes. To examine to what
extent overlap occurs between both repair systems, we generated TCR–deficient mice with selective inactivation of NER in
postnatal neurons. These mice develop dramatic age-related cumulative neuronal loss indicating DNA damage substrate
overlap and synergism between TCR and NER pathways in neurons, and they uncover the occurrence of spontaneous DNA
injury that may trigger neuronal degeneration. We propose that, while Csa
2/2 and Csb
2/2 TCR–deficient mice represent
powerful animal models to study the mechanisms underlying myelin abnormalities in CS, neuron-specific inactivation of
NER in TCR–deficient mice represents a valuable model for the role of NER in neuronal maintenance and survival.
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Introduction
DNA is continuously damaged by spontaneous hydrolytic
decay, endogenous metabolites (e.g. reactive oxygen species,
malondialdehyde), and environmental genotoxins. DNA lesions
can give rise to irreversible mutations and chromosomal aberra-
tions that may trigger carcinogenesis. Alternatively, DNA damage
can cause replicative senescence and cell death, which promotes
the process of aging [1]. Cumulative DNA damage has also been
implicated in the functional deterioration and degeneration of
long-living post-mitotic cells such as neurons [2]. To counteract
the harmful effects of DNA injuries, cells have a variety of DNA
surveillance and repair systems. The importance of these genome
maintenance pathways for human health is well illustrated by a
heterogeneous set of inherited syndromes that are associated with
defects in specific DNA repair pathways resulting in cancer
predisposition, developmental abnormalities, accelerated aging
and neurodevelopmental or neurodegenerative abnormalities
[1,3–5].
Nucleotide excision repair (NER) is a key DNA repair pathway
for removal of UV-induced DNA damage and a wide range of
other helix-distorting lesions, including bulky chemical adducts
and specific types of oxidative damage [1]. In NER the DNA
lesion is removed as a part of a 25–30 nucleotide single-strand
fragment excised via a multi-step reaction followed by resynthesis
of the excised strand [4,6–8]. NER can be divided into two
subpathways that differ in the damage recognition step: While
global genome NER (GG-NER) removes distorting DNA damage
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specifically targets transcription-blocking lesions in the template
strand of active genes to allow recovery of transcription after
damage induction [1,4,7,8]. Several NER proteins have functions
beyond NER, which is particularly evident for the transcription/
repair factor TFIIH, which is required for the local opening of the
damaged DNA in NER, but in addition plays an essential role in
transcription. Furthermore, several lines of evidence indicate that
TC-NER components are involved in repair of transcription-
blocking lesions independent of the NER core complex, putatively
via recruitment of other repair mechanisms. The term transcrip-
tion-coupled repair (TCR) has been used to designate this broader,
still poorly defined repair process [7,9,10].
NER gene defects are associated with a heterogeneous set of
rare clinical syndromes, whose characteristics can be explained by
the type of NER pathway that is affected or by defects in
additional functions of these NER components in other DNA
repair pathways or transcription. Selective defects in GG-NER,
resulting from mutations in the XPC and XPE (also termed UV-
DDB2) genes encoding GG-NER-specific damage recognition
proteins, cause xeroderma pigmentosum (XP), a photosensitivity
syndrome characterized by UV-hypersensitivity, pigmentation
abnormalities and UV-induced skin cancer predisposition
[11,12]. Cancer-predisposition in XP-C patients is explained by
bulky lesions that accumulate over the entire genome causing
mutations after replication [1]. Selective defects in TC-NER result
from mutations in the genes encoding the proteins CSA or CSB,
both of which are selectively recruited to stalled RNA polymerase
II [13]. Mutations in CSB and CSA are associated with Cockayne
syndrome (CS), a progeroid disorder characterized by cachectic
dwarfism and progressive neurological abnormalities, in addition
to skin photosensitivity [14–16]. CS patients do not show cancer
predisposition, which is explained by the normal function of GG-
NER, and indicates that TC-NER is not required for preventing
cancer. On the other hand, most CS pathological features cannot
be explained by the sole loss of TC-NER function as they do not
occur in XP-A patients, which show a combined GG-NER/TC-
NER deficiency, resulting from mutations in the gene encoding for
the core NER protein XPA. Thus XP-A patients present with UV-
hypersensitivity and skin cancer predisposition, like XP-C patients,
usually in combination with progressive neurological abnormalities
(see below) [17–19], but they do not develop cachectic dwarfism
and other progeroid features of CS patients. This has led to the
notion that the CS phenotype is largely the consequence of an
overall TCR defect, i.e., the inability to rescue transcription
arrested by NER- and non-NER-types of DNA damage [7,20,21].
In addition it has been suggested that CS is associated with
transcriptional abnormalities independent of DNA lesions
[7,22,23].
The complementarity of NER and TCR DNA repair pathways
and disorders resulting from deficiencies in these processes is also
illustrated by XPCS patients, which display both XP and CS
symptoms. XPCS is caused by mutations in the XPB or XPD
genes, both encoding helicases of the transcription/repair factor
TFIIH, or in the XPG gene, encoding the endonuclease that
mediates the 39 incision of the excision step [24–27]. Mutations
in the XPB and XPD genes may also cause pure XP or
trichothiodystrophy (TTD), a disorder that is characterized by
sulphur-deficient hair, in association with a variable spectrum of
abnormalities that usually include neurodevelopmental deficits.
Mutations that cause XP preferentially afflict the NER activity of
TFIIH, while TTD mutations destabilize the TFIIH complex
causing exhaustion of TFIIH in specific cell types [27]. The
occurrence of CS symptoms in association with specific XPB and
XPD mutations point to functions beyond NER and basal
transcription presumably linked to non-NER TCR activities akin
to CSA and CSB [22,27–31]. XPG mutations associated with
XPCS have been proposed to destabilize the interaction between
XPG and TFIIH, while mutations causing XP disrupt its
endonuclease activity, further pointing to a non-NER activity
underlying CS symptoms [25,26,32].
The presence of progressive juvenile or adult onset neurological
abnormalities in XP-A patients has provided a strong hint that the
NER pathway is important for neuronal function and mainte-
nance [14,19,33–36]. The neurological symptoms are character-
ized by progressive sensory and motor deficits, as well as cognitive
deterioration and emotional abnormalities, and are associated with
widespread neuronal degeneration in multiple brain areas and the
spinal cord [17–19]. XP-C patients (who are only deficient in GG-
NER) do not develop overt neurological symptoms, indicating that
the neurodegenerative changes follow from TC-NER or a
combined GG-NER and TC-NER dysfunction. A dominant role
of the TC-NER pathway in the nervous system is also suggested by
the occurrence of XP-A-like progressive neurological abnormal-
ities in CS patients. However, in CS patients neuropathological
changes are primarily characterized by myelin abnormalities,
while neurons and their axons seem relatively unaffected
[14,35,37,38]. An additional complicating factor is formed by
patients carrying CSA or CSB mutations that develop UV-sensitive
syndrome, a disorder that is characterized by the skin abnormal-
ities of CS in the absence of other CS features. The lack of typical
CS features in these patients has been linked to residual TCR
activities required for repair of oxidative DNA lesions, while TC-
NER of UV-induced DNA lesions was deficient [39]. In sum, the
data from XP and CS patients indicate that combined deficiency
of GG-NER and TC-NER as in XP-A patients predominantly
afflicts neurons, while deficiencies of TCR predominantly cause
myelin problems. However, the precise mechanisms underlying
the differential cellular vulnerabilities in XP and CS nervous
system are still poorly defined, in particular in CS where distinct
Author Summary
Metabolism produces reactive oxygen species that dam-
age our DNA and other cellular components, and as such it
contributes to the aging process, including neuronal
degeneration. Accordingly, genetic disorders associated
with impaired DNA damage repair are frequently associ-
ated with premature onset of aging pathology in a variety
of tissues, including the brain. This is well-illustrated by the
progeroid DNA repair syndromes xeroderma pigmento-
sum (XP) and Cockayne syndrome (CS), in which patients
suffer from defects in nucleotide excision repair (NER) and
transcription-coupled repair (TCR), two partially overlap-
ping DNA repair systems that remove helix-distorting and
transcription-blocking lesions, respectively. We have used
a panel of XP and CS mice (including conditional double-
mutant animals) to systematically investigate the impact of
NER and TCR defects on neuronal degeneration. We have
shown that, whereas a TCR defect causes white matter
pathology, a NER defect can result in age related cumula-
tive loss of neurons. These findings well match the
neuropathology observed in CS and XP patients, under-
scoring the impact of spontaneous DNA damage in the
onset of neuronal aging. Therefore, the XP and CS mouse
models serve as valuable tools to delineate intervention
strategies that combat age-associated pathology of the
brain.
Neuronal Degeneration in DNA Repair-Deficient Mice
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neurons [7,22].
Although previous studies have shown that mouse models for
XP, CS, XP-CS and TTD reliably recapitulate the repair defect
(i.e. GG-NER and/or TC-NER/TCR), UV-sensitivity and skin
cancer predisposition associated with the corresponding NER
syndromes (Table 1 and Table 2), this does not apply to the
neurological features [40]. In particular, Xpa
2/2 mice fail to
exhibit obvious neurological symptoms and neuropathological
changes observed in human XP-A [41–44]. Likewise, Csa
2/2 and
Csb
2/2 mouse models for CS, except for photoreceptor-loss, do
not show overt neurological abnormalities [45,46]. However, a
detailed systematic neuropathological analysis is still lacking. In the
present study we reexamined various NER and TCR mutant
mouse models for neurodegenerative abnormalities to assess and
dissect the contribution of the different repair systems in
preventing neurodegeneration. To permit analysis of the direct
contribution of DNA repair defects to neurological functioning, in
the absence of pathology elsewhere in the body due to systemic
DNA repair deficiency, we have generated a Cre-lox-based
conditional Xpa mouse model that enables inactivation of the
Xpa gene selectively in neurons. In particular, we used this novel
mouse model to examine the effect of combined NER and TCR
deficiency on neuronal survival.
Results
Sporadic p53 activation in astrocytes and neurons
throughout the central nervous system of Cockayne
syndrome mice
As a first step to study the role of NER and TCR in maintaining
neuronal integrity, we have re-examined six previously reported
mutant mouse models for the presence of neuropathological
abnormalities. These mouse lines consisted of Xpc
2/2 mice, in
which only GG-NER is completely inactive [43,47]; Xpa
2/2 mice,
in which both GG-NER and TC-NER are fully deficient [41,43];
Csa
2/2 and Csb
2/2 mice, in which TC-NER and presumably the
entire TCR pathway is abrogated, but which have proficient GG-
NER [45,46,48]; Xpd
XPCS mice (homozygous for the G602D
XPCS mutation in the Xpd gene), which carry a partial GG-NER
and a partial TCR defect [49]; and Xpd
TTD mice carrying Xpd
alleles with the R722W TTD mutation, that also have a partial
GG-NER and TCR defect, in addition to TFIIH instability
causing transcriptional insufficiency in terminally differentiated
cells with consequent brittle hair and nails (Table 1 and Table 2)
[50,51]. Consistent with their respective NER-deficiencies the
mutant mice manifest various degrees of increased susceptibility to
UV- and 7,12-dimethylbenz[a]anthracene (DMBA)-induced skin
carcinogenesis (Table 1 and Table 2). TCR-deficient mice to
varying extent exhibit other symptoms like reduced growth,
osteoporosis, photoreceptor loss, liver and kidney aging, and
reduced lifespan (Table 2) [20,28,44–56].
Consistent with previous reports [43–50] analysis of thionin-
and hematoxylin/eosin-stained brain sections revealed that the
gross anatomy and histological organization of all central nervous
system regions of aforementioned mutant mice were indistinguish-
able from wild type animals at 6 months of age, precluding overt
neurodevelopmental deficits or neuronal degeneration. Also the
central nervous system of 70–100 week old Csb
2/2 and Xpa
2/2
mice appeared normal. Therefore, to examine the possible
occurrence of subtle abnormalities, we employed immunohisto-
logical approaches. First, to determine whether central nervous
system cells of the NER-deficient mice experience genotoxic stress,
we studied the expression of the transcription factor p53, which is
activated by multiple types of DNA damage [57]. p53-immuno-
reactive cells were not detected in the central nervous system of
wild-type and Xpd
TTD mice. Instead, occasional cells with p53-
immunoreactive nuclei were observed throughout the nervous
system of Csa
2/2, Csb
2/2 and Xpd
XPCS mice, while even more
sporadic p53 induction was visible in Xpa
2/2 and Xpc
2/2 animals
(Figure 1). p53-staining was associated with neurons (NeuN-
positive cells; Figure 1A), astrocytes (GFAP- or S100-positive cells;
Figure 1C and Figure S1), and sometimes oligodendrocytes (APC-
positive cells; Figure S1). The relative amount of glial versus
neuronal p53-staining varied per brain region, and to some extent
per mouse model: in cerebellar cortex the large majority of p53-
positive cells consisted of neurons, in the neocortex p53-positive
cells were neurons or non-neuronal cells in equal amounts,
while in spinal cord and the brainstem reticular formation
p53-immunoreactivity was predominantly or almost exclusively
associated with glia cells (Figure 1E and Figure S1). p53-
immunoreactive neurons generally showed normal nuclear
morphologies, in contrast to most p53-immunoreactive glial cells.
For instance, a subset of p53-positive astrocytes in spinal cord and
the brainstem reticular formation showed nuclei with a DAPI-
negative centre that was intensely p53-positive (Figure S1).
Another nuclear abnormality of p53-positive glia consisted of a
larger nuclear size (Figure S1). Also in Xpa
2/2 and Xpc
2/2
nervous systems p53-positive cells consisted of both neurons and
astrocytes, but their frequency was too low to allow systematic
analysis of the relative proportion of neuronal versus non-neuronal
cells in different brain areas. Taken together the data indicate that
mice with a complete (Csa
2/2, Csb
2/2) or severe partial (Xpd
XPCS)
TCR defect show nuclear p53 expression in sporadic neurons and
glia throughout the nervous system, pointing to the occurrence of
genotoxic stress.
Table 1. NER defect and sensitivity to genotoxins of embryonic fibroblasts isolated from NER–deficient mouse models.
Mouse Model NER defect Sensitivity to genotoxins References
GG-NER TC-NER UV c-irradiation Paraquat
Xpa
2/2 +++ 22 [43,47,55]
Xpc
2/2 + 2 + 22 [43,47]
Csa
2/2 2 ++ 22 [20,46,48,53,54,55]
Csb
2/2 2 ++ + +[20,45,46,48,53,54,55]
Xpd
XPCS +/2 ++ + +[28,49]
Xpd
TTD +/2 +/2 ++ /2 N.D. [50,51,53]
doi:10.1371/journal.pgen.1002405.t001
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regions of Cockayne syndrome Csa
2/2, Csb
2/2, and
Xpd
XPCS mice
To further investigate the presence of degenerative changes in
the nervous system of NER-deficient mice we examined microglia
cells which proliferate and acquire activated morphologies in
conditions of neuronal and glial damage [58,59]. Immunostaining
for Iba-1, a marker of all microglia cells and Mac2 (also known as
galectin-3), a protein selectively expressed by activated phagocy-
tosing microglia [58], did not, or only sporadically, reveal
activated microglia cells in the nervous system of wild-type,
Table 2. Cancer susceptibility and principal features of NER–deficient mice.
Mouse Model Cancer susceptibility
Median
survival Principal features References
untreated UV-induced DMBA-induced
Xpa
2/2 +/2 ++ ++ trend of
reduced
survival
normal weight, photosensitive skin and eyes, increased
mutation frequencies, impaired spermatogenesis
[41,43,44,52,53,56]
Xpc
2/2 +/2 ++ + mildly
reduced
normal weight, photosensitive skin and eyes, increased
mutation frequencies
[43,47,52,56]
Csa
2/2 2 + ND ND mildly reduced weight, photosensitive skin and eyes,
retinal photoreceptor degeneration, increased
vulnerability to c-irradiation
[20,46,48,54,55]
Csb
2/2 2 ++ normal mildly reduced weight, photosensitive skin and eyes, no
changes in mutation frequency, retinal photoreceptor
degeneration, increased vulnerability to c-irradiation
[20,45,48,54,55]
Xpd
XPCS ++ + + + mildly
reduced
mildly reduced weight, smaller testis [28,49]
Xpd
TTD 2 ++ mildly
reduced
reduced weight, TTD-like brittle hair, mild osteoporosis,
signs of accelerated aging, anaemia
[50,51,53]
doi:10.1371/journal.pgen.1002405.t002
Figure 1. p53 expression in brain and spinal cord of adult NER– and TCR–deficient mice. A–C) Double-labeling confocal images showing
p53-NeuN (A, B) and p53-S100 (C) double-labeled cells in neocortex of a 25 week old Csb
2/2 mouse. Scale bars: 25 mm (A, B) and 10 mm( C ) .D ,E )B a r
graphsshowingthedensityofp53-labeledcells,andtherelativeamountofp53-neurons(i.e.percentageofNeuN-positivep53-labeled).Valuesaremeans
6 SE of 3 or 4 mice, while value per mouse is based on analysis of 4 (neocortex [NCx], cerebellar cortex [Cb]) or 10 (lumbar L4 spinal cord [SpC]) sections.
doi:10.1371/journal.pgen.1002405.g001
Neuronal Degeneration in DNA Repair-Deficient Mice
PLoS Genetics | www.plosgenetics.org 4 December 2011 | Volume 7 | Issue 12 | e1002405Figure 2. TCR–deficient mice show microglia and astrocyte activation in the white matter. A–F) Mac2-immunostaining of activated
microglia in the medullary reticular formation of 25 week old wild-type and NER-deficient mice showing the presence of Mac2-positive microglia cells
in the reticular formation of Csa
2/2 (B), Csb
2/2 (C) and Xpd
XPCS (E) mice. G) Bar graph showing the density of Mac2-labeled cells in the medullary
reticular formation and corpus callosum of NER-mutant mice. Values are means 6 SE of 3 or 4 mice, while values per mouse are based on analysis of 4
sections. H) Plot of Mac2-positive cells in selected transverse brain sections of 25 week old Csb
2/2 mouse illustrating the widespread distribution of
activated microglial cells in regions containing myelinated axons such as the corpus callosum (cc), the internal capsule (ic), the fornix (f), the cerebellar
white matter (wm), the mesencephalic (MesRF) and medullary reticular formation. No or a low number of Mac2- immunoreactive cells occur in grey
matter regions, such as the Neocortex (NCx), the hippocampal subfields (DG [dentate gyrus], CA1 and CA3), amygdala (Am), piriform cortex (Pir), the
cerebellar cortical granular (gl) and molecular layers (ml), and the medial (MVe) and lateral vestibular (LVe) nuclei. I–O) Photomicrographs and optical
density measurements (O) of GFAP-immunoperoxidase staining in the medullary reticular formation of NER-deficient mice showing increased staining
in Csa
2/2, Csb
2/2 and Xpd
XPCS mice as compared to the other genotypes. Optical densities were determined from TIFF files using MetaMorph 4.6
image analysis software. Values are means 6 SE of 3 mice, while values per mouse are from 3 sections. To minimize variability resulting from the
staining procedure all sections used for the graph were stained in a single session using the same reagents. Scale bars: 50 mm (D, L).
doi:10.1371/journal.pgen.1002405.g002
Neuronal Degeneration in DNA Repair-Deficient Mice
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2/2, Xpc
2/2 and Xpd
TTD mice (Figure 2 and Figure S2). In
contrast, prominent levels of activated microglia were present
throughout the nervous system of Csa
2/2, Csb
2/2 mice and, to a
somewhat lesser extent, Xpd
XPCS mice (Figure 2, Figures S2 and
S3). Typically, Mac2-positive microglia cells occurred in small
clusters in areas with myelinated fibers. Thus, in the forebrain
Mac2-positive microglial cells were concentrated in the corpus
callosum, the anterior commissure, the capsula interna and the
fornix, while in the caudal brain high levels of activated microglia
occurred in the cerebellar white matter, throughout the reticular
formation and in fiber tracts in the brainstem (Figure 2, Figure S2
and Figure S3). We performed a more in-dept analysis of the time
of onset and course of these features in Csb
2/2 mice at different
ages. Prominent levels of Mac2-positive cells were already present
before 10 weeks of age (not shown), and the density of Mac2-
positive cells did not show a distinct increase with age (Figure 2G).
To examine whether microglia activation is paralleled by
changes in astrocytes, we also stained for glial fibrillary acidic
protein (GFAP), an astrocytic protein up-regulated under
conditions of neuronal injury. Increased GFAP staining was
observed in the nervous system of mouse mutants that also showed
microglial cell activation, i.e. Csa
2/2, Csb
2/2 and Xpd
XPCS mice
(Figure 2I–2O). Increased GFAP staining was most prominent in
the brainstem reticular formation and spinal cord (Figure S4). No
obvious changes in GFAP staining were noted in some white
matter areas such as the corpus callosum and the capsula interna
of Csa
2/2, Csb
2/2 and Xpd
XPCS mice, which may be explained by
relatively higher baseline GFAP-immunoreactivity in these areas
in wild-type mice. To further examine astrocytic changes in white
matter areas, we examined the expression of Hsp25 (also known as
Hsp27 or Hspb1), a small heat shock protein that is expressed at
high levels in a subset of astrocytes in conditions of injury [60].
Indeed Csa
2/2, Csb
2/2 and Xpd
XPCS, but not Xpa
2/2, Xpc
2/2 and
Xpd
TTD nervous systems showed the appearance of intensely
Hsp25-immunoreactive astrocytes in multiple regions including
the brainstem reticular formation, spinal cord, the white matter of
cerebellum and the corpus callosum forebrain (Figure S4).
The above data indicate that Csa
2/2, Csb
2/2 and Xpd
XPCS mice
show microglia and astrocyte activation in multiple central
nervous system areas, indicative of the occurrence of cellular
degeneration or another detrimental process. As these mutant
mice also displayed p53-immunoreactive cells, we performed
double labeling of p53 with Mac2 to determine whether p53-
immunoreactive cells are contacted by phagocytosing microglia
cells. However, Mac2-positive microglia cells were never found in
the vicinity of p53 cells (Figure 3A). Instead, Mac2-positive
microglia were frequently in close proximity of oligodendrocytes
(Olig2 and APC-positive; Figure 3B, 3C), that otherwise showed a
healthy appearance with normal DAPI-stained nuclei. These data
indicate that glial abnormalities may be associated with subtle
alterations in oligodendrocytes. To examine whether the presence
of activated microglia was associated with myelin abnormalities,
we performed double labeling of neurofilament-H and myelin
basic protein to outline axons and their myelin sheets. No
differences in myelin basic protein staining were observed in spinal
white matter and corpus callosum of wild-type and Csb
2/2 mice
(not shown).
Finally, to determine whether Csa
2/2, Csb
2/2 and Xpd
XPCS
mice show increased levels of cell death of oligodendrocytes or
other cells, we stained for active caspase 3, which is a final
executioner caspase associated with multiple cell death pathways
[61]. Very sporadically caspase 3 immunoreactive cells were
observed in the nervous system of all mutant mouse models; all
positive cells showing morphologies compatible with glial cells
(Figure 3D, 3E). Quantitative analysis in spinal cord indicated that
the number of active caspase 3-positive cells, although still very
low, was higher in Csa
2/2, Csb
2/2 and Xpd
XPCS mice as compared
to the other genotypes (Figure 3F). It was not possible to determine
whether the active caspase 3 cells represented oligodendrocytes or
astrocytes because they did not stain for cellular markers such as
GFAP, S100, APC ad NeuN. Consistent with active caspase 3
staining, a silver degeneration procedure, that outlines degener-
ating neurons and their processes, indicated that none of the NER
mice showed detectable levels of neuronal degeneration at 26
weeks of age. Taken together the data show that Csa
2/2, Csb
2/2
and Xpd
XPCS mice develop prominent microglia cell activation as
well as astrocytic changes that may be mostly triggered by subtle
oligodendrocyte abnormalities.
Neuron-specific inactivation of Xpa causes age-
dependent neuronal loss in Csb
2/2 mice
The NER mouse models investigated above exhibited either no
detectable neuronal abnormalities or evidence for only subtle
neuronal dysfunction and degeneration, indicating that inactiva-
tion of NER or TCR pathways by itself is not sufficient to
significantly affect long-term survival of neurons in mice. Previous
studies disclosed synergistic deleterious effects of intercrossing XP
(Xpa
2/2 or Xpc
2/2) with CS (Csa
2/2, Csb
2/2, Xpd
XPCS) mice,
resulting in double mutants with very short life span and dramatic
progeroid features [49,62–64]. This raises the possibility that
neuronal degeneration may be achieved by inactivation of
multiple NER components afflicting both NER and TCR
pathways. However, the very short lifespan as well as the serious
systemic abnormalities of the double mutant mice precludes
systematic analysis of neuronal degeneration, which could also be
an indirect consequence of impaired function of other organs and
systems. To address this issue, we generated a Cre-lox-based
conditional Xpa mouse model that enables selective inactivation of
the Xpa gene in postnatal neurons of CS mouse lines and hence to
study the effect of combined TCR and NER inactivation in
neurons of adult mice that do not suffer from other severe deficits.
To establish a conditional Xpa knockout mouse model, we
generated a targeting construct in which exon 4 of the Xpa gene is
fused in frame to the mouse Xpa cDNA containing the remaining
coding sequence and including a synthetic polyA sequence,
followed by a PGK promoter-driven hygromycin selectable
marker gene, and a LacZ-GFP fusion gene (Figure 4A). The
splice acceptor-Murfi cassette ensures proper splicing and
translational stops in all frames respectively when the Xpa gene
is knocked out (Figure 4A). The functionality of this conditional
genomic-cDNA fusion allele was tested in UV-hypersensitive
Xpa
2/2 ES cells (Figure S5). These experiments showed that the
Xpa
c conditional allele fully averted the UV-hypersensitivity of
Xpa
2/2 ES cells (Figure S5). Next Xpa
c/+ ES cells, obtained by
transfection of IB10 ES cells (Figure 4B), were used for blastocyst
injections and subsequent generation of Xpa
c/+ mice. To determine
whether Cre recombinase was capable of excising the floxed Xpa
sequence in vivo, we generated Xpa
c/2/Cag-Cre mice by crossing
Xpa
c/+ mice with Xpa
+/2 mice carrying a Cag-promotor driven Cre
transgene (Cag-Cre), which drives Cre recombinase expression
immediately after conception [65]. Southern blot analysis showed
Cre-recombinase excision of the floxed sequence in Xpa
c/2/Cag-
Cre embryos at ,100% efficiency (Figure 4C). Consistent with
ubiquitous recombination, Xpa
c/2/Cag-Cre embryos stained blue
upon X-gal staining due to LacZ expression, while Xpa
c/2
embryos remained unstained (Figure 4D). Xpa
c/2/Cag-Cre mouse
embryonic fibroblasts (MEFs) like Xpa
2/2 MEFs [41] showed
severe UV-hypersensitivity, while Xpa
c/2 MEFs show wild-type
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conditional allele (Figure 4E). Next, we crossed Csb
2/2/Xpa
c/+
and Csb
2/2/Xpa
+/2/Cag-Cre mice to obtain Csb
2/2/Xpa
c/2 and
Csb
2/2/Xpa
c/2/Cag-Cre m i c e .I nl i n ew i t ht h ep h e n o t y p eo fCsb
2/2/
Xpa
2/2 mice [63], Csb
2/2/Xpa
c/2Cag-Cre pups displayed severe
postnatal growth deficits, cachexia, disturbed gait, and death before
weaning, while Csb
2/2/Xpa
c/2 littermates did not develop overt
pathology (Figure 4F). Taken together, these data demonstrate that
we have generated a valid conditional Xpa mouse model that
enables us to study the Csb
2/2/Xpa
2/2 phenotype in a cell or
tissue-specific manner.
To study the effect of Xpa inactivation in the absence of Csb,
specifically in postnatal neurons, we crossed Csb
2/2/Xpa
c/2 mice
with a calcium/calmodulin-dependent protein kinase IIa (Cam-
KIIa) Cre transgenic line that expresses Cre-recombinase
selectively in postnatal neurons throughout the forebrain [66,67].
Forebrain-specific recombination was confirmed by PCR and
analysis of LacZ expression. Csb
2/2/Xpa
c/2/CamKIIa-Cre mice
grew into young adulthood without any noticeable phenotype,
showed a normal body weight and appearance at the age of 6
months, but from the age of 9–12 months became smaller and
exhibited reduced weight as compared to littermates with other
genotypes, i.e. CamKIIa-Cre, Csb
2/2CamKIIa-Cre, Xpa
c/2CamKIIa-
Cre and Csb
2/2/Xpa
c/2 littermates (Figure 5A, Figure S6). In
addition, from 9–12 months of age, Csb
2/2/Xpa
c/2/CamKII-Cre
mice started to display seizure behavior, characterized by episodes
of immobility. Subsequently, Csb
2/2/Xpa
c/2/CamKII-Cre mice
became moribund, all animals dying prematurely between the age
of 12 and 22 months (Figure 5B), while animals from littermates
with other genotypes survived up to 24 months (the oldest age
examined). Analysis of locomotor behavior using the accelerating
rotarod assay demonstrated that Csb
2/2/Xpa
c/2/CamKIIa-Cre
mice performed within the normal range at the age of 6 months,
but showed reduced performance at 12 months (Figure S6). For
further analysis of behavioral abnormalities, we used an open-field
exploratory test. This test revealed that Csb
2/2/Xpa
c/2/CamKIIa-
Cre mice avoided exploration of the central part of the open field,
which is considered a measure of anxiety-related behavior [68].
Total movement time and distance were the same as for the other
groups ruling out impaired mobility as explanation for the
difference in the test. The ratio of the ambulatory activity in the
center and the total walking distance was already reduced at 3
months of age, and further declined at 6 and 12 months of age
(Figure 5C).
Macroscopic examination of the brain of Csb
2/2/Xpa
c/2/
CamKIIa-Cre mice revealed no obvious changes at 3 months, mild
atrophy of the cortex at 6 months, and severe atrophy of the cortex
at older age (Figure S6). The sizes of olfactory bulbs, cerebellum
and spinal cord were the same as in other groups. Analysis of
coronal sections of 12–16 month-old Csb
2/2/Xpa
c/2/CamKIIa-Cre
brains showed a large reduction in cortical thickness, atrophy of
other telencephalic areas (i.e. hippocampus, caudatus-putamen
and septum), and dramatically enlarged lateral ventricles
(Figure 5D, 5E). No abnormalities were observed in non-
telencephalic areas, consistent with specific inactivation of the
conditional Xpa allele in forebrain neurons. Atrophy of telence-
phalic areas was paralleled by a marked increase in GFAP
immunoreactivity, while GFAP staining in other brain areas was
the same as in Csb
2/2/Xpa
c/2 and Csb
2/2 mice (Figure 5F).
Atrophied brain areas also showed loss of the neuronal somato-
Figure 3. Mac2-positive microglia cells enwrap oligodendrocytes in CS mice. A) Double-labeling confocal images of p53 and Mac2 in DAPI-
counterstained spinal cord section of Csb
2/2 mouse showing that Mac2-immunoreactive microglia cells do not colocalize with p53-labeled cells. B, C)
Triple-labeling confocal images of Mac2 and the oligodendrocyte markers Olig2 and APC showing Mac2-immunoreactive microglia cells that closely
embrace mature oligodendrocytes labeled by Olig2 and APC. The dashed line in (B) outlines the nucleus of the Mac2-positive microglia cell. Arrows in
B and C indicate oligodendrocytes contacted by Mac2-positive microglia cells. D–F) Photomicrographs and bar graph of active caspase 3
immunoreactive cells in spinal cord of 25 week old Csa
2/2, Csb
2/2 and Xpd
XPCS mice. Values are means 6 SE of 3 or 4 mice, while value per mouse is
based on analysis of 10 cervical spinal cord sections. Scale bars: 20 mm.
doi:10.1371/journal.pgen.1002405.g003
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c/2 mouse with a floxed genomic/cDNA fusion construct. A) Schematic representation of the
wild-type mouse Xpa locus (exon 2 to 6), the targeting construct, the conditional Xpa allele, and the conditional Xpa allele following Cre-recombinase-
mediated inactivation. In addition the knock out allele with a neomycin (NEO) marker cassette, as present in the non-conditional Xpa mouse model is
shown [41]. In the conditional construct, exon 4 was fused in frame to the mouse Xpa cDNA (containing the remaining coding sequence and
including a synthetic polyA sequence), followed by a PGK promoter-driven hygromycin (HYGRO) selectable marker gene. LoxP sites were introduced
in intron 3 and downstream of the hygromycin marker to allow Cre-mediated excision of the cDNA and hygromycin marker gene, yielding an Xpa
allele lacking exon 4, known to act as a null allele. A LacZ-GFP fusion marker gene, preceded by a splice acceptor (SA) and an internal ribosomal entry
(IRES) was included to allow visualization of inactivation of the conditional Xpa allele. Open and gray boxes represent exon and cDNA sequences,
respectively. The splice acceptor-Murfi cassette ensures proper splicing and translational stops in all frames respectively when the Xpa gene is
knocked out. B) Southern analysis of wild-type ES cell DNA transfected with the conditional Xpa construct. DNA was digested with EcoRI and
hybridized with an intron 5/exon 6 probe, external to the targeting construct. Wild-type and targeted alleles gave fragments of 16 and 12 kb,
respectively. C) Southern blot analysis of DNA from E13.5 Xpa
c/2 and Xpa
c/2/Cag-Cre embryos. DNA was digested with EcoRV and hybridized with a
LacZ probe. Intact and Cre-inactivated conditional Xpa alleles are represented by 2.4 and 10 kb fragments, respectively. D) LacZ staining of E13.5
Xpa
c/2 and Xpa
c/2/Cag-Cre embryos, indicating inactivation of the conditional Xpa allele in Xpa
c/2/Cag-Cre embryos only. E) Survival of wild-type,
Xpa
c/2 and Xpa
c/2/Cag-Cre MEFs, exposed to increasing doses of UV-C light. F) Photograph of 16-day old Csb
2/2/Xpa
c/2 and Csb
2/2/Xpa
c/2/Cag-Cre
littermates, the latter showing severely reduced size.
doi:10.1371/journal.pgen.1002405.g004
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Xpa in Csb
2/2 mice. A) Mean body weight of CamKIIa-Cre, Csb
2/2CamKIIa-Cre, Xpa
c/2CamKIIa-Cre and Csb
2/2/Xpa
c/2/CamKIIa-Cre mice. Values are
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particular in the hippocampal CA1 region, indicative of neuronal
degeneration (Figure S7).
Staining for p53 revealed a prominent increase in the number of
p53 immunoreactive neurons in the forebrain of Csb
2/2/Xpa
c/2/
CamKIIa-Cre mice as compared to Csb
2/2 mice and other
genotypes that showed essentially no p53 immunoreactive cells
(Figure 6A, 6D). In addition, Csb
2/2/Xpa
c/2/CamKIIa-Cre fore-
brain exhibited a strong increase in neurons expressing ATF3
(Figure 6B, 6D), a stress-inducible transcription factor that is
induced following genotoxic stress via p53-dependent and -
independent pathways [69,70]. Finally, direct evidence for
neuronal degeneration was obtained by staining for active caspase
3 and by using a silver staining procedure: active caspase 3 staining
revealed intensely stained neuronal profiles (Figure 6C, 6D).
Similarly, the silver degeneration staining method outlined infre-
quent argyrophylic neuronal profiles, reflecting neurons that are in
the process of dying. In addition, the silver staining uncovered
high levels of argyrophilic axonal degeneration in the corpus
callosum, the fimbria-fornix, the anterior commissure, and the
cortifugal fiber bundles coursing in the capsula interna, the
cerebral peduncle and the pyramidal tract (Figure 6E), which is
consistent with the selective occurrence of neuronal degeneration
in forebrain neurons. Together these data indicate that Csb
2/2/
Xpa
c/2/CamKII-Cre mice display chronic neuronal degeneration
that in the long term has resulted in severe neuronal loss and
atrophy of the forebrain regions.
The distribution of degenerative changes in Csb
2/2/Xpa
c/2/
CamKII-Cre mice is consistent with the specific inactivation of Xpa
in forebrain neurons induced by CamKII-promotor driven Cre-
recombinase expression [66,67], and highlights the vulnerability of
Csb-deficient forebrain neurons to loss of Xpa function. To
determine the effect of Xpa inactivation in other neuronal
populations of the Csb
2/2 brain, we crossed Csb
2/2Xpa
c/2 mice
with a postnatal Purkinje cell specific Cre (L7-Cre) transgenic line
[71] to obtain Csb
2/2/Xpa
c/2/L7-Cre mice. Analysis of motor
behavior with accelerating rotarod revealed no or very mild motor
abnormalities in Csb
2/2/Xpa
c/2/L7-Cre mice at the age of 3 and 6
months (the oldest age examined). However, neuropathological
analysis disclosed multiple signs of selective Purkinje cell
degeneration resembling pathological changes in forebrain
neurons of Csb
2/2/Xpa
c/2/CamKII-Cre mice (Figure 6). Abnor-
malities included the presence of argyrophilic axonal degenera-
tion, specifically in the cerebellar white matter and cerebellar
nuclei, i.e. the areas that contain Purkinje cell axons (Figure 6F),
and sporadic argyrophilic debris in the molecular and Purkinje cell
layer, while no argyrophilic changes occurred in other brain areas.
In addition, the Purkinje and molecular layers also showed a
strong increase in GFAP-immunoreactivity (Figure 6G), while
staining for calbindin, a protein that in the cerebellum is selectively
expressed in Purkinje cells, revealed calbindin-negative regions in
the molecular layer, indicative of loss of Purkinje cells (Figure 6H).
Furthermore, a subset of Purkinje cells (with morphologies varying
from relatively normal to severely atrophic cells) displayed strong
nuclear ATF3 staining (Figure 6I), which was distinct from the
non-specific cytoplasmic staining of Purkinje cells produced by the
ATF3 antibody. Nuclear ATF3 staining was not observed in
Purkinje cells (nor other cerebellar neurons) of wild-type, Csb
2/2,
Csb
2/2/Xpa
c/+/L7Cre, Csb
2/2/Xpa
c/2 and Xpa
c/2/L7-Cre, as well
as forebrain-specific Csb
2/2/Xpa
c/2/CamKII-Cre mice. Quantifi-
cation of ATF3-immunoreactive Purkinje cells in mid-sagittal
sections of 6 month-old Csb
2/2/Xpa
c/2/L7-Cre mice (n=3)
indicated that 1.360.6% (Mean 6 SE) of Purkinje cells were
ATF3-positive. Finally, staining for active caspase 3 revealed
infrequent (,1 in 5000) positive Purkinje cells (Figure 6J). In
conclusion, the data obtained with Csb
2/2/Xpa
c/2/L7-Cre mice
further demonstrate that the addition of an Xpa defect to Csb-
deficient neurons results in pronounced neuronal degeneration.
Discussion
To determine the importance of the NER and TCR DNA
repair pathways for neuronal integrity and survival, we first
conducted a comparative analysis of neuropathological abnormal-
ities in six mouse models for the human syndromes XP, CS, XPCS
and TTD. The major finding of this analysis is that CS-like/TCR-
deficient Csa
2/2, Csb
2/2 mice and, to a lesser extent, Xpd
XPCS
mice, develop a characteristic set of mild degenerative changes
that was predominantly characterized by microglia activation in
regions with myelinated axons, in the absence of obvious signs of
axonal degeneration. This microglia activation did not occur in
the XP-like GG-NER-defective Xpc
2/2 and total NER-defective
Xpa
2/2 mutant animals, nor in the TTD-like Xpd
TTD mouse. In
view of very limited signs of neuronal degeneration in NER- and
TCR-deficient mice, respectively, we also investigated the effect of
combined NER- and TCR-deficiency on neuronal survival. For
this purpose we generated a Cre-lox based conditional Xpa
knockout mouse that was crossed with neuron-specific Cre lines
and TCR-deficient Csb
2/2 mice. These experiments showed that
combining NER and TCR-defects in neurons causes progressive
neuronal degeneration and disclose a functional overlap as well as
functional complementarity of the NER and TCR repair
pathways.
Identification of a CS–like neuropathological phenotype
in TCR–deficient mouse mutants
The abnormalities identified in the CS (Csa
2/2 and Csb
2/2),
and XPCS (Xpd
XPCS) mice consisted of 1) the presence of activated
phagocytosing microglia cells in regions containing myelinated
axons such as the corpus callosum, the brainstem reticular
means 6 SE (n=8 to 13/group). Note the loss of body weight in Csb
m/m/Xpa
c/2/CamKIIa-Cre mice after the age of 25 weeks. * represent P,0.05, as
compared to other groups of the same age (one-way Anova with Tukey’s post-test). B) Survival curve of Csb
2/2/Xpa
c/2/CamKIIa-Cre mice (n=13) as
compared to wild type and single mutant littermates (combined n=13). C) Representative examples of open field plots (C2) and quantification of the
distance moved in the center as compared to total distance moved (C1), showing reduced ambulatory behavior of Csb
2/2/Xpa
c/2/CamKIIa-Cre mice
(n=6) in the center of the field. Note that the center/total distance ratio is already reduced in 3 month-old Csb
m/m/Xpa
c/2/CamKIIa-Cre mice, and
decreases upon further aging. * in panel C, P,0.05, compared to other groups of the same age (one-way Anova with Tukey’s post test). D, E) Coronal
4 mm thick, haematoxylin/eosin-stained paraffin sections of 15 and 65 week old Xpa
c/2/CamKIIa-Cre and Csb
2/2/Xpa
c/2/CamKIIa-Cre mouse brains;
sections grossly correspond to sections 0.5 to 1 mm anterior to the bregma (D) and 1.5 to 2 mm posterior to the bregma (E) as depicted in the mouse
brain atlas of Paxinos and Franklin [85]. 65 week old Csb
2/2/Xpa
c/2/CamKIIa-Cre show dilated ventricles, and atrophy of the neocortex (NCx),
hippocampus, the caudatus-putamen (CPu) and the septum. CA3, CA3 hippocampal subfields; DG, dentate gyrus; Th, thalamus; LS, lateral septum; lv,
lateral ventricle. F) GFAP-immunoperoxidase staining in coronal brain sections of 65 week-old Xpa
c/2CamKIIa-Cre, Csb
2/2 and Csb
2/2Xpa
c/2CamKIIa-
Cre shows increased GFAP staining in the neocortex (NCx), hippocampus and amygdala of Csb
2/2Xpa
c/2CamKIIa-Cre mice. GFAP staining in the
thalamus (Th) was the same as in Xpa
c/2CamKIIa-Cre and Csb
2/2 mice.
doi:10.1371/journal.pgen.1002405.g005
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2/2 mice. A–D)
Neurolucida plot (A), representative photomicrographs (B, C) and bar graph (D) of p53 (A, D), ATF3 (B, D) and active caspase 3 (C, D) staining in the
cortex of 65 week old Csb
2/2 and Csb
2/2Xpa
c/2CamKIIa-Cre mice showing an increase in the number of p53- and ATF3 immunoreactive cells and the
appearance of caspase 3 labeled neurons in the cortex of Csb
2/2Xpa
c/2CamKIIa-Cre mice. Values in bar graph in d represent means 6 SE from 3 mice
per group. E) Silver degeneration staining in the caudatus-putamen shows a high level of argyrophilic fibers in the capsula interna (ci) and corpus
callosum (cc) of 16 month-old Csb
2/2Xpa
c/2CamKIIa-Cre mice while no stained fibers occurred in these fiber tracts in wild-type (not shown), Csb
2/2
and Xpa
c/2CamKIIa-Cre mice. F–J) Photomicrographs of sagittal cerebellar sections of 25-week old Csb
2/2 (F1–J1) and Csb
2/2Xpa
c/2L7-Cre mice (F2–
J2). F) Silver degeneration staining shows a high level of argyrophilic fibers in the deep cerebellar nuclei (DCN) and the white matter (wm) of Csb
2/2
Xpa
c/2L7-Cre cerebellum (arrow in F2). G) GFAP-immunoperoxidase staining shows increased GFAP staining in the molecular (ml) and Purkinje cell
(Pcl) layers Csb
2/2Xpa
c/2L7-Cre cerebellar cortex, while no change occur in the granule cell layer (Gcl). H) Calbindin-immunoperoxidase staining
reveals calbindin-negative regions in the molecular layer (arrow in H2) of Csb
2/2Xpa
c/2L7-Cre cerebellar cortex. I) A number of Purkinje cells showed
strong nuclear ATF3 staining (arrow in I2). Note that the ATF3 antibody also outlines Purkinje cells because of non-specific cytoplasmatic staining of
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p53-immunoreactive nuclei. Microglia activation was frequently
accompanied by signs of astrocytosis indicative of a central
nervous tissue injury response. We did not find an association
between microglia activation and p53-positive cells, and neither
was microglia activation associated with detectable axonal
degeneration. However, activated microglia cells were often in
close contact with oligodendrocytes. These data indicate that
microglia activation follows from oligodendrocyte or myelin
abnormalities. Previous electron microscopic analysis did not
reveal abnormalities in the morphology and thickness of myelin
sheets in Csb
2/2 mice [45], and in the current study, apart from
evidence suggesting a minor increase in apoptosis of oligodendro-
cytes, we did not identify other overt oligodendrocytic abnormal-
ities. Hence, the precise cellular abnormality that triggers
microglia activation in myelinated regions of Csa
2/2, Csb
2/2,
and Xpd
XPCS mice remains to be determined. Importantly,
however, the presence of activated microglia is consistent with
the notion that irregular patchy myelination with minimal axonal
degeneration is a dominant neuropathological hallmark of CS
[14,22,35,37,72]. Hence, our findings together with human
neuropathological data strongly indicate that oligodendrocyte
abnormalities are a prime defect in CS. We also show that Xpd
TTD
mice, unlike Xpd
XPCS mice, do not develop microglia activation in
myelinated areas. This is in line with the notion that myelin
abnormalities in TTD patients and Xpd
TTD mice result from
developmental deficits and arise via different mechanisms than in
CS patients [14,22]. Our data further illustrate that specific point
mutations in the Xpd gene result in different cellular deficits and
associated pathologies in the mouse, mimicking the different
pathologies in patients [27,31,49].
The second abnormality that we identified in the CS (Csa
2/2
and Csb
2/2) and the XPCS (Xpd
XPCS) mouse nervous systems
consisted of sporadically distributed p53-immunoreactive neurons
and astrocytes, and, albeit very infrequent, oligodendrocytes. p53-
immunoreactive cells occurred in all brain areas, but the
proportion of neuronal versus glial p53-immunoreactive cells
varied among brain areas. Thus, in cortex and cerebellum a large
proportion of p53-positive cells are neurons while in the brain stem
and spinal cord the far majority, if not all, p53-positive cells are
glial cells. The expression of p53, which is known to be activated
by multiple types of DNA damage and which mediates neuronal
degeneration [57], provides indirect evidence for the occurrence of
genotoxic stress, which can be explained by cumulative DNA
damage resulting from compromised DNA repair. Interestingly, a
subset of p53-positive astrocytes showed abnormal nuclear
morphologies, which is compatible with reports of astrocytic
nuclear abnormalities in CS patients [38,72,73], and further
indicate that astrocytes are vulnerable to loss of TCR function.
We did not observe abnormal nuclear morphology in p53-
immunoreactive neurons, nor did we obtain direct evidence for
ongoing neuronal death using two neuropathological markers for
dying neurons, i.e. active caspase 3 immunoreactivity, and silver
degeneration staining. However, the process of death and removal
of individual neurons may occur within a few hours, making the in
vivo detection of asynchronous sporadically distributed cell death
challenging [74,75]. Hence, our methods do not exclude the
possibility of a low frequency of ongoing neuronal degeneration.
The lack of an obvious neurodegenerative phenotype in the CS
mouse models is compatible with the neuropathology of CS
patients indicating relatively modest neuronal degeneration in
most brain areas [35,38,72,73]. Interestingly, cerebellar granule
cells, which are among the most severely affected populations of
neurons in CS patients [76], most frequently showed p53
immunoreactivity in the CS mice, indicative of a differential
vulnerability of cerebellar granule cells to loss of TCR function in
both CS patients and mouse models. Furthermore, p53-immuno-
reactive granule cells have been demonstrated in autopsy cases of
CS [76].
Together our data indicate that Csa
2/2, Csb
2/2, and Xpd
XPCS
mice reproduce the major aspects of CS neuropathology, albeit in
a mild form, which may explain the absence of macroscopic
neuropathological and obvious neurological deficits associated
with CS. In this context it would be interesting to know whether
patients with UV-sensitivity syndrome (UVSS), also carrying
mutations in CSA and CSB genes, develop the same mild
abnormalities. The presence of activated microglia in UVSS
patients would support the notion of a continuum of CS
phenotypes ranging from CS type II to UVSS [16] as also
suggested by a CS patient with a CSB null mutation displaying
adult-onset neurological symptoms [37]. As the pathologies of
Csa
2/2, Csb
2/2, and Xpd
XPCS mice are relatively similar, our data
also indicate that the CS neurodegenerative features can not be
explained by molecular mechanisms that do not include all three
proteins. Furthermore, the data indicate that the CS neurodegen-
erative changes result from deficits in a shared non-NER activity
of these proteins as Xpa
2/2 mice with complete loss of GG-NER
and TC-NER function did not reproduce the neuropathological
features that we observed in Csa
2/2, Csb
2/2, and Xpd
XPCS mice
(see below). This is consistent with a broader TCR process, which
encompasses transcription-coupled repair of non-NER/non-dis-
torting transcription-blocking lesions involving CS and TFIIH
proteins.
A marginal nervous system phenotype in GG-NER– and
entirely NER–deficient mice
TheGG-NER-defectiveXpc
2/2andtotalNER-defectiveXpa
2/2
mutant mice at 26 weeks of age showed very low levels of p53-
immunoreactive neurons and astrocytes, which nevertheless was
higher than in Xpd
TTD and wild-type mice of the same age, in which
we did not detect any cells with nuclear p53 immunoreactivity
throughout the nervous system. These data suggest that Xpa
2/2 and
Xpc
2/2 mice have a central nervous system phenotype, albeit
marginal. In case of Xpc
2/2 mice the phenotype is compatible with
that of XP-C patients that, although neurologically and cognitively
asymptomatic, may develop mild neurodegenerative changes [19].
However, in Xpa
2/2 mice the phenotype is very different from the
severe progressive neurodegenerative changes of many XP-A
patients, which develop juvenile or adult progressive neuronal
degeneration throughout the central and peripheral nervous system
depending on the severity of NER dysfunction [17,19,33,34,36].
Neurons from Xpa
2/2 mice display considerably increased
sensitivity to UV radiation [77] and the cross-linking agent cisplatin
[78], consistent with loss of NER function and excluding
redundancy of NER activity by other proteins at least for the lesions
induced by these agents. The discrepancies between human and
rodents may follow from differences in the rate of production and
type of DNA lesions caused by endogenous metabolites, and from
the shorter lifespan of mice.
these cells. J) Active caspase 3 antibody stains sporadic Purkinje cells in Csb
2/2Xpa
c/2L7-Cre cerebellar cortex (arrow head in J2). Calibration Bars: Bars:
500 mm (F2), 100 (B1), 50 mm (E, H2), 25 mm (C1, J2).
doi:10.1371/journal.pgen.1002405.g006
Neuronal Degeneration in DNA Repair-Deficient Mice
PLoS Genetics | www.plosgenetics.org 12 December 2011 | Volume 7 | Issue 12 | e1002405Synergistic effects of NER and TCR deficiencies in
neuronal degeneration
To investigate the effect of combined NER and TCR-deficiency
on neuronal survival, we generated a Cre-lox-based conditional
Xpa mouse model to inactivate Xpa selectively in postnatal neurons
in Csb
2/2 mice. The use of a conditional Xpa mouse model was
required in view of our previous findings that global Csb
2/2/
Xpa
2/2 double mutant animals show degenerative changes in
multiple organs as well as a very short life span [62,63], precluding
prolonged analysis of neurodegeneration and separation from
direct and indirect consequences. Our data show that Csb
2/2 mice
with neuron-specific inactivation of Xpa develop progressive
neuronal degeneration, indicating that the XPA protein (and the
NER pathway as a whole) is essential for the survival of mouse
neurons in the absence of the CSB protein. The time course and
distribution of neurodegenerative changes indicate that the
affected neurons degenerate asynchronously over a prolonged
time window. When Xpa is inactivated in forebrain neurons of Csb-
deficient animals, mild behavioral abnormalities were observed at
3 months of age, while death, associated with severe atrophy of
forebrain areas, occurred between 12–21 months of age. Analysis
of the distribution of dying neurons, as identified by active caspase
3 or ATF3 staining, showed that the level of ongoing neuronal
degeneration at a given time point was low. Similarly, in Csb-
deficient mice with selective inactivation of Xpa in Purkinje cells
which were analyzed at a single time point, a subset of Purkinje
cells had disappeared (identified as loss of calbindin staining), a
very small subset was in the process degenerating or dying (ATF3
and caspase 3 staining), while a subset showed a normal
appearance consistent with asynchronous degeneration. Such an
asynchronous neuronal degeneration is consistent with cell death
resulting from the accumulation of stochastic DNA damage
[79,80], and strongly resembles the pattern of neuronal degener-
ation in Ercc1
D/2 mice that are impaired in several DNA repair
systems, i.e. nucleotide excision repair, interstrand crosslink repair
and double strand break repair [81].
Together, the data with conditional Xpa/Csb-deficient mice
indicate that adult neurons in rodents are vulnerable to
endogenous DNA lesions when deficient in both NER and
TCR, but are able to cope with these lesions when either the TCR
or NER pathway are defective. While the NER and TCR pathway
share the TC-NER activity, they have non-overlapping activities
consisting of GG-NER and the still poorly defined non-NER TCR
activities. In neurons, factors of the GG-NER machinery, in
particular XPC, have been shown to operate in a specialized type
of transcription-associated repair, termed domain-associated
repair (DAR). DAR operates on both strands in active genes,
including regions of a gene that RNA polymerase II does not reach
and has been proposed to complement TCR [80], and it may
possibly mask or compensate for the loss of TCR [80]. This is
supported by the demonstration that XPC-deficient mice that are
selectively deficient in GG-NER when crossed with CSB-deficient
mice have a similar phenotype as Csb
2/2Xpa
2/2 mice [64]. Our
data indicate that Xpc
2/2 and Xpa
2/2 animals develop similar
marginal central nervous system phenotypes consisting of highly
sporadic p53-positive cells. Together these data suggest that in
mice Xpc is equally important as Xpa for the central nervous
system. Also in man, XPC-deficiency may result in subtle
neurodegenerative changes [19], although XPA-deficiencies
results in much more severe neurodegenerative phenotypes
[14,17,19].
Non-NER TCR has been proposed to operate in conditions of
specific transcription-blocking oxidative DNA lesions, putatively
via recruitment of alternative DNA repair pathways [7,9,10]. This
explains why cells from CS mice and CS patients, unlike XPA-
deficient cells, show increased vulnerability to some types of
oxidative stress, and may more readily accumulate oxidative DNA
lesions [9,20,39,82]. In addition, increased levels of oxidative
DNA lesions have been reported in brain tissue of Csb
2/2 mice
[10]. Thus, the inability to cope with oxidative lesions may explain
the pathological phenotype of CS mice, as well as the severe
degenerative phenotype in the conditional Xpa-deficient Csb
2/2
mice. However, the precise identity of DNA lesions and the
question whether the CS phenotype truly results from a repair
deficiency remains to be further explored.
In summary, our data indicate that the GG-NER, TC-NER,
and non-NER TCR mechanisms operate together in maintaining
the integrity of neurons, and that the absence of one pathway
aggravates the risk for deficiencies in other pathways, explaining
the severe neurodegenerative phenotype in double mutants. The
extent to which a combined deficiency of NER and TCR is
detrimental to non-neuronal nervous systems cells remains to be
determined in future studies by selectively inactivating Xpa in
these cells in TCR deficient mice. We propose that neuron-specific
inactivation of Xpa-i nCsb-deficient mice represents a powerful
model for studying XP neurological disease and the role of NER in
neurons. As neurologic symptoms seen in XP are hallmark
features of age-related neurodegenerative diseases these mice may
also reproduce aspects of accelerated aging.
Materials and Methods
Mutant mice
Experiments were performed in accordance with the ‘‘Principles
of laboratory animal care’’ (NIH publication no. 86-23) and the
guidelines approved by the Erasmus University animal care
committee. Animals used were Xpc
2/2, knock-out for the Xpc gene
[47], Xpa
2/2, knock-out for the Xpa gene [41], Csa
2/2, knock-out
for the Csa gene [46], Csb
2/2, in which the CS1AN patient
mutation is mimicked resulting in a null mouse [45], Xpd
XPCS,
homozygous for the G602D XPCS point mutation in the Xpd
gene [49] and Xpd
TTD, carrying Xpd alleles with the R722W TTD
mutation [50] bred in a pure C57BL/6J background.
To obtain a conditional Xpa knockout mouse model, we
generated a targeting construct in which exon 4 was fused in frame
to the mouse Xpa cDNA (containing the remaining coding
sequence and including a synthetic polyA sequence), followed by
a PGK promoter-driven hygromycin selectable marker gene
(Figure 4A). A genomic clone containing 10 kb of the 129ola
mouse Xpa locus (pMMXP3-6#13; [41]), was used to re-clone an
approximately 10 kb size BamHI fragment, containing exon 3 to
6, into the psp72 vector. Following XbaI digestion, part of exon 4
and intron 4 was replaced by a cassette containing the mouse Xpa
cDNA including the natural 39 UTR and polyadenylation signal
followed by a PGK promoter-driven hygromycin selectable
marker and a LoxP site respectively. Next, the SmaI site
downstream of the LoxP site was used to introduce a cassette
containing a splice acceptor sequence (SA), an ochre stopcodon
multiple reading frame insertion (Murfi) linker, a ribosomal entry
site (IRES), and a LacZ/GFP fusion reporter gene (as a blunted
SalI fragment). The SmaI site in intron 3 was used to insert a
blunted XhoI-SalI loxP fragment from pGEM30 (kindly provided
by Dr. W. Gu, University of Cologne). This targeting construct,
which was designated pIP-Xpa-con, contains homologous arms of
4 kb at the 59 end and 5 kb at the 39 end.
The 129Ola-derived ES cell line IB10 was electroporated with
NotI linearized pIP-Xpa-con DNA and cultured in gelatin-coated
dishes as described before [45]. Hygromycin (Roche, 843555) was
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100 mg/ml. Cells were maintained under selection for 7–8 days,
after which clones were isolated and expanded in 24-well plates.
Genomic DNA from individual hygromycin-resistant clones was
digested with EcoRI and analyzed by Southern blotting using a
500 bp DraI fragment (‘‘intron 5/exon 6’’ probe; obtained from a
7.5 kb PCR fragment spanning exon 5 and 6). EcoRI digested
DNA from targeted ES clones was subsequently screened with the
hygromycin (cDNA) probe to confirm proper homologous
recombination at the 59 end of the targeting construct.
For the generation of Xpa
c/2 ES cells, we followed the same
procedure as described above, except that Xpa
2/2 ES cells [54]
were used. To test the functionality of the loxP sites, Xpa
c/+ ES
cells were electroporated with a purCre plasmid (kindly provided
by Dr. M. Jaegle, Erasmus MC) and cultured on gelatin dishes as
described. Puromycin (Sigma, P7255) was added 24 hr after
electroporation to a final concentration of 100 mg/ml. Cells were
maintained under selection for 3 days. Genomic DNA from
individual puromycin-resistant clones was digested with EcoRV
and analyzed by Southern blotting using a 500 bp PCR fragment
of the LacZ gene. Properly targeted IB10 ES clones were
karyotyped and cells from two independent clones (selected for
the presence of 40 chromosomes) were injected into 3.5-day-old
C57BL/6J blastocysts. Male chimeric mice were mated with
C57BL/6J females to obtain heterozygote offspring.
Heterozygous males and females were bred to Xpa
+/2 as well as
Csb
2/+ animals to ultimately obtain Xpa
c/2, Xpa
c/+ and Csb
2/2/
Xpa
c/2 animals. Genotyping was initially performed by Southern
blot analysis of genomic DNA obtained from tail biopsies of 8–10-
day-old born pups. A description of PCR-based genotyping
methods is given below. Xpa
c/2 and Csb
2/2/Xpa
c/2 animals were
also interbred with Cag-Cre [65], CamKII-Cre (line L7ag#13)
[66,67], and L7-Cre (line L7Cre-2, [71]) Cre-recombinase trans-
genic mice, which were kindly provided by A. de Wit
(ErasmusMC), S. Zeitlin (Columbia University), and J.J. Barski
(Max-Planck-Institute of Neurobiology, Martinsried, Germany),
respectively.
Primary mouse embryonic fibroblasts from the various single
and double mutant mouse models (three independent lines per
genotype) were isolated from day 13.5 embryos and cultured as
described before [83].
Mice and cells were genotyped by PCR for the wild-type and
(conditional) mutant Xpa or Csb alleles using a primer mix that (per
genotype) amplifies both the wild-type and targeted alleles in a
single reaction [41]. The presence or absence of the conditional
Xpa allele was detected by PCR using primers XpaFex3 (59-TTT
GAT CTG CCA ACG TGT G-39) and XpaRex4 (59-GCT TCG
CTT CTG TCT TGG T-39). The presence or absence of the Cre
transgene was detected by PCR using primers 59-GCA CGT TCA
CCG GCA TCA AC-39 and 59-CGA TGC AAC GAG TGA
TGA GGT TC-39. Both products were amplified with the same
PCR program: 5 min. 93uC, 1 min. 93uC, 1 min. 58uC, 2.5 min.
72uC (35 cycles of the latter three steps), 5 min. 72uC.
LacZ staining of embryos and cells
Cells or embryos were fixed for 30 minutes at 4uC in a buffer
containing 1% paraformaldehyde, and subsequently washed
3615 minutes with PBS/0.01% NP40. Cells or embryos were
stained overnight at 37uC in dark in a staining solution containing
3.1 mM K3Fe(CN)6, 3.1 mM K4Fe(CN)6, 0.15 M NaCl, 1 mM
MgCl2 and 1 mg/ml X-gal (Roche Applied Sciences, USA, IN).
For tissues, the same procedure was used, except that the fixation
time was extended to 3 hours.
DNA repair assays
Seeded cultures at a density of 1000 spontaneously immortal-
ized MEFs on a 6 cm dish were exposed to different doses of UV-
C (254 nm, Philips TUV lamp). The cells were allowed to grow for
another 7 days after which the resulting clones were fixed, stained
and counted. For each independent cell line, the amount of
surviving clones at each dose of UV, 3 dishes per dose, was
calculated as the percentage of clones on the plate without UV.
Behavioral assays
For the open field test, animals were placed for 30 min in a
square (26626626 cm) open field box, equipped with photobeam
sensors (TruScan E63 10–12, Coulbourn Instruments), and
attached to a computer to record the following ambulatory
parameters: total distance, center distance, total move time, center
time and corner time. Each test session lasted 30 minutes, and
data were collected in 5 minute intervals. The anxiety ratio was
calculated by dividing center distance by total distance. Rotarod
analyses were performed as described previously [84].
Immunohistochemical and histopathological procedures
Mice were anesthetized with pentobarbital and perfused
transcardially with 4% paraformaldehyde, and brains were
dissected out, weighed, and postfixed overnight in 4% parafor-
maldehyde at 4uC. For standard histological analyses brains were
paraffin-embedded, sectioned at 4 mm and stained with haema-
toxylin/eosin solution. For other staining procedures brain
specimen were embedded in gelatin blocks [81] and sectioned at
40 mm with a freezing microtome. Sections were processed, free
floating, using immunofluorescence or a standard avidin-biotin–
immunoperoxidase complex method (ABC; Vector Laboratories)
with diaminobenzidine (0.05%) as the chromogen. In addition, a
selected number of frozen sections were processed for a silver
staining procedure that selectively labels dying neurons and their
processes [81].
Immunoperoxidase-stained sections were analyzed and photo-
graphed using a Leica (Nussloch, Germany) DM-RB microscope
and a Leica DC300 digital camera. Sections stained for
immunofluorescence were analyzed with a Zeiss (Oberkochen,
Germany) LSM 510 confocal laser scanning microscope using
40x/1.3 and 63x/1.4 oil-immersion objectives.
Primary antibodies reported in this study are as follows: mouse
anti-APC (Calbiochem, clone CC-1, 1:2000); rabbit anti-activating
transcription factor 3 (ATF3; Santa Cruz Biotechnology, Santa
Cruz, 1:1000); rabbit anti-cleaved caspase 3 (Asp175; Cell
Signaling Technology, 1:200); mouse anti-calbindin (Sigma, clone
CB-955, 1:10000); rabbit anti-GFAP (DAKO, 1:5000); mouse
anti-GFAP (Sigma, clone G-A-5, 1:20000); rabbit anti-HSP25
(Stressgen, 1:7000); rabbit anti-Iba1 (WAKO Chemicals, 1: 2000);
rat anti-Mac2 (Cedarlane, 1:2000); mouse anti-MAP2 (Millipore,
clone AP20, 1:200); rat anti-myelin basic protein (Millipore,
MAB386, 1:500); mouse anti-NeuN (Millipore MAB377, 1:2000);
rabbit anti-neurofilament-H (Millipore, 1:2000); rabbit anti-olig2
(IBL, 1:2000); rabbit anti-p53 (Leica, 1:2000); mouse anti-S100B
(Sigma, clone 1B2, 1:2000); and guinea pig anti-VGLUT1
(Millipore, 1:2000). For avidin-biotin–peroxidase immunocyto-
chemistry biotinylated secondary antibodies from Vector Labora-
tories (Burlingame, CA) diluted 1:200 were used. FITC-, cyanine 3
(Cy3)-, and Cy5-conjugated secondary antibodies raised in donkey
(Jackson ImmunoResearch, West Grove, PA) diluted at 1:200 were
used for immunofluorescence.
Immunoperoxidase-stained sections were analyzed and photo-
graphed using a Leica DM-RB microscope and a Leica DC300
digital camera. To determine the relative staining intensity of
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and optical densities were determined from TIFF files using
MetaMorph 4.6 image analysis software. Optical densities
determined in rectangular areas of 2006250 mm. To minimize
variability resulting from the staining procedure this analysis was
performed with sections stained in a single immunostaining
session.
Statistical analyses
Statistical analyses were done with GraphPad Prism software
(San Diego, USA). Means from different age groups, and different
transgenic mouse lines were compared using one-way-ANOVA
with Tukey’s post tests.
Supporting Information
Figure S1 P53 expression in brain and spinal cord of adult
NER– and TCR–deficient mice. Double-labeling confocal images
showing p53-NeuN (A, H, I), p53-S100 (B), p53-GFAP (C, D, F,
G), and p53-APC (E) double-labeling in cerebellar cortex, the
mesencephalic reticular formation and spinal cord of NER-
deficient mice. Note in A three p53-immunoreactive cells, two of
which (the cell indicated by the arrow and the cell shown in A0) are
cerebellar granule cells. Also note p53-positive astrocytes with
large intensely p53-immunoreactive nucleus (A9), or with nuclei
with a DAPI-negative center that are intensely immunoreactive for
p53 (arrow in B9, C). The nucleus of the p53-immunoreactive
astrocyte shown in G also shows abnormal DAPI staining. Panel (I)
illustrates an intensely p53-immunoreactivity motor neuron in the
spinal cord of an Xpd
XPCS mouse. Notably, p53 immunoreactive
neurons, while occasionally present in spinal cord and brain stem
of Xpd
XPCS mice were never observed in spinal cord and brainstem
of Csa
2/2 and Csb
2/2 mice, illustrating subtle differences between
these mouse lines. Scale bars: 25 mm (A, B, I), 20 mm (E) and
10 mm (C, D, F, G, H).
(TIF)
Figure S2 Microglia activation in spinal cord of Cockaybe
syndrome mutant mice. Double-labeling confocal images of Iba-1
and Mac2 staining in spinal cords of 25 week old wild-type, Csa
2/2,
Csb
2/2, Xpa
2/2, Xpc
2/2, Xpd
XPCS, and Xpd
TTD mice showing
Mac2-positive microglia in spinal cords of Csa
2/2, Csb
2/2 and
Xpd
XPCS mice (arrows in B, C, D, G). All Mac2-positive microglia
cells show an activated morphology as revealed by Iba-1 staining
(D). DH, dorsal horn; IZ, intermediate zone; lf, lateral funiculus; vf,
ventral funiculus. Scale bar in A, 250 mm.
(TIF)
Figure S3 TCR–deficient mice show microglia activation in the
white matter. Photomicrographs of Mac2-stained transverse brain
sections of a 25 week old wild-type and Csb
2/2 mouse showing a
high concentration of Mac2-positive microglia cells occurs
throughout the nervous system of Csb
2/2 mouse (E–H). Individual
or clustered Mac2-positive microglia cells are concentrated in
regions containing myelinated axons such as the corpus callosum
(cc), the internal capsule (ic) bundles in the striatum, the fimbria
fornix (f), the cerebellar white matter, the mesencephalic (MesRF),
and medullary reticular formation (RF). No or a low number of
Mac2-immunoreactive cells occur in grey matter regions, such as
the Neocortex NCx), the hippocampal subfields (DG [dentate
gyrus], CA1 and CA3), and the medial (MVe) and lateral (LVe)
vestibular nuclei. Scale bar in A: 200 mm.
(TIF)
Figure S4 Increased GFAP-and Hsp25 immunoreactivity in
Cockayne syndrome mutant mice. A–Q) Photomicrographs of
GFAP-immunoperoxidase staining in transverse sections at the
level of caudal hippocampus and mesencephalon (A–E), the
cerebellum and the medulla oblongata (F–J), and spinal cord (O–
Q). Note increased GFAP-staining in mesencephalic (MesRF,
arrows in B–D), and medullary (G9–I9) reticular formation of
Csa
2/2, Csb
2/2 and Xpd
XPCS mice as compared to other
genotypes. Also note increased GFAP-immunoreactivity in spinal
cord (P, Q), while no changes in GFAP staining occurred in
cerebellar cortex (L) and neocortex (N) of Cockayne syndrome
mice. In white matter areas such as the corpus callosum there was
no distinguishable increase in GFAP-immunoreactivity in Cock-
ayne syndrome mice as compared to wild-type. This may be
explained by relatively high levels of baseline GFAP-immunore-
activity in white matter in wild-type. R–V) Photomicrograph and
bar graph illustrating the presence of Hsp25-immunoreactive
astrocytes in reticular formation and cerebellar white matter of
Csa
2/2, Csb
2/2 and Xpd
XPCS mice. Hsp25 immunoreactivity is
also associated with endothelial cells in both wild-type and Csb
2/2
sections. Values in bar graph are means 6 SE of 3 mice based on
analysis of three sections per mouse. Scale bars: 1 mm (F) and
500 mm (P), 25 mm (R).
(TIF)
Figure S5 Characterization of the conditional Xpa construct in
Xpa-deficient ES cells. A) To test the functionality of the genomic/
cDNA fusion conditional Xpa construct (Figure 4A), it was
transfected in Xpa
2/2 ES cells [20]. Targeted Xpa
c/2 ES clones
were detected by Southern blot analysis. DNA was digested with
EcoRI and hybridized with an intron 5/exon 6 probe, external to
the targeting construct. Knockout and conditional alleles gave
fragments of 16 and 12 kb, respectively. B) Survival curves of wt
(circles), Xpa
2/2 (diamonds) and Xpa
c/2 (squares) ES cells,
exposed to increasing doses of UV-C light, showing that .Xpa
2/2
ES cells targeted with Xpa
c construct displayed the same
sensitivity to UV as wild-type ES cells. This indicates that the
conditional Xpa allele fully averted the UV-hypersensitivity of
Xpa
2/2 ES cells. Subsequent transient expression of CRE
recombinase in Xpa
c/2 ES cells reinstated UV-hypersensitivity
(data not shown).
(TIF)
Figure S6 Weight loss, reduced rotarod performance, and brain
atrophy after forebrain neuron-specific knockout of Xpa in Csb
2/2
mice. A) Photograph of 9 month old male Xpa
c/2/CamKIIa-Cre
and Csb
2/2/Xpa
c/2/CamKIIa-Cre littermates, illustrating smaller
appearance of the latter. B) Bar graphs of performance in an
accelerating rotarod task of CamKIIa-Cre, Csb
2/2CamKIIa-Cre,
Xpa
c/2CamKIIa-Cre and Csb
2/2/Xpa
c/2/CamKIIa-Cre (n=18)
mice. * represent P,0.05, as compared to other groups of the
same age and the same mice at younger age (one-way Anova with
Tukey’s post test). C) Brains of Xpa
c/2/CamKIIa-Cre and Csb
2/2/
Xpa
c/2/CamKIIa-Cre mice sacrificed at 15, 25 and 65 weeks of age;
note severeatrophy of the cortex of the 65 week old Csb
2/2/Xpa
c/2/
CamKIIa-Cre m o u s e( w h i t ea r r o w s ) .
(TIF)
Figure S7 Loss of MAP2-immunoreactivity in hippocampus
after forebrain neuron-specific knockout of Xpa in Csb
2/2 mice.
Double labeling confocal immunofluorescence of MAP2 and
VGlut1 in the hippocampus of 16 month-old Xpa
c/2CamKIIa-Cre
(A) and Csb
2/2Xpa
c/2CamKIIa-Cre (B) mice. In addition to severe
atrophy the hippocampus of Csb
2/2Xpa
c/2CamKIIa-Cre mice
show a marked reduction of MAP2 immunoreactivity in the
CA1 subfield and the dentate gyrus (DG; arrows in B1, and
compare B19 with A19). Immunoreactivity of the vesicular
glutamate transporter 1 (VGluT1), which marks a large portion
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reduced labeling was specific for MAP2 (compare A29 with B29).
Bar, 200 mm.
(TIF)
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